McCutcheon Krista, O'Hara Edward, Fei David
BioAnalytical Research and Development, Genentech, Inc., South San Francisco, CA, USA.
Immunol Invest. 2005;34(2):199-213.
Analytical methods characterizing the immunogenicity of therapeutic proteins are useful for monitoring, characterizing and predicting reactions to biopharmaceuticals. A multiplexed assay capable of isotyping the specific IgG, IgA, IgM and IgE (IgGAME) antibody responses against a biotherapeutic was demonstrated in a hyper-immunized cynomolgus monkey, over a 15-month period. The quantitative range of the antibody measurements was determined to be 15 ng/ml to 50 ng/ml in 10% serum. By the use of any biotinylated or fluorescently tagged therapeutic as a detector, this multiplexed isotyping assay can be broadly applied to human and non-human primate IgG, IgA, IgM and IgE immunogenicity studies.
表征治疗性蛋白质免疫原性的分析方法对于监测、表征和预测对生物制药的反应很有用。在一只超免疫食蟹猴中,在15个月的时间里证明了一种能够对针对生物治疗药物的特异性IgG、IgA、IgM和IgE(IgGAME)抗体反应进行亚型分型的多重检测方法。在10%血清中,抗体测量的定量范围确定为15 ng/ml至50 ng/ml。通过使用任何生物素化或荧光标记的治疗剂作为检测器,这种多重亚型分型检测可广泛应用于人和非人灵长类动物的IgG、IgA、IgM和IgE免疫原性研究。